4//SEC Filing
XANTHOPOULOS KLEANTHIS G 4
Accession 0001587221-18-000002
CIK 0001587221other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:01 PM ET
Size
5.8 KB
Accession
0001587221-18-000002
Insider Transaction Report
Form 4
XANTHOPOULOS KLEANTHIS G
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-02+30,000→ 30,000 totalExercise: $0.53Exp: 2028-01-02→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]As a result of a 1-for-20 reverse stock split of the common stock of the Company, which became effective at 5:00 p.m. Eastern Time on January 25, 2018 (the "Reverse Split"), the exercise price has increased from $0.53 per share to $10.60 per share.
- [F2]As a result of the Reverse Split, the number of shares of the Company's common stock underlying the stock option has decreased from 30,000 shares to 1,500 shares.
- [F3]The shares underlying the option shall vest on the first anniversary of the date of grant.
Documents
Issuer
Zosano Pharma Corp
CIK 0001587221
Entity typeother
Related Parties
1- filerCIK 0001283304
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:01 PM ET
- Size
- 5.8 KB